Robeco Institutional Asset Management B.V. Collegium Pharmaceutical, Inc Transaction History
Robeco Institutional Asset Management B.V.
- $51.9 Billion
- Q4 2024
A detailed history of Robeco Institutional Asset Management B.V. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 10,237 shares of COLL stock, worth $333,623. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,237
Previous 114,965
91.1%
Holding current value
$333,623
Previous $4.44 Million
93.4%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding COLL
# of Institutions
249Shares Held
36.2MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$189 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$85.9 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$76.5 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$69.8 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$54 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.11B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...